obtained her membership of the Royal College of Physicians in 2009. She moved to Cambridge University Hospital for further hematology training and was based in Addenbrookes hospital for 3 years and in associated district general hospitals. She spent a year in Sydney, Australia with a focus on pathology training. She obtained her FRCPath in 2014 and completed her training in 2015. In addition to her medical degree she completed a molecular physiology degree focused on the P2X2 receptor. At Princess Margaret her interest is focused on the management of leukemia in patients unfit for intensive chemotherapy and early phase clinical trials